Type II endoleak: conservative management is a safe strategy
- PMID: 25042332
- DOI: 10.1016/j.ejvs.2014.06.035
Type II endoleak: conservative management is a safe strategy
Abstract
Objective: Type II endoleak is the most common complication after endovascular abdominal aortic aneurysm repair (EVAR); however, its natural history is unclear. The aim of this study was to examine the incidence and outcomes of type II endoleak, at a single institution after EVAR.
Methods: A total of 904 consecutive patients who underwent EVAR between September 1995 and July 2013 at a single centre were entered onto a prospective database. All patients were followed up by duplex ultrasound (DUSS). Patients who developed type II endoleak were compared for preoperative demographics, mortality, and sac expansion.
Results: A total of 175(19%) patients developed type II endoleak over a median follow-up of 3.6 years (1.5-5.9 years); 54% of type II endoleaks spontaneously resolved within 6 months (0.25-1.2 years). No difference was found in preoperative demographics or choice of endograft between the two groups. Survival was significantly higher in the group with type II endoleak (94.1% vs. 85.6%; p = .01) and this effect was most pronounced in those with late type II endoleaks (97.7% vs. 85.6% p = .004). No difference was seen in aneurysm-related mortality or rate of type I endoleak between the two groups. Freedom from sac expansion (>5 mm from preoperative diameter) was significantly lower in the group of patients with type II endoleak (82.5% vs. 93.2%, p = .0001); however, at a threshold of >10 mm from preoperative diameter no difference was seen.
Conclusions: Patients with isolated type II endoleak demonstrate equivalent aneurysm-related mortality and an improved survival.
Keywords: AAA; Aneurysm; EVAR; Endoleak; Type II.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Re: 'Type II Endoleak: Conservative Management Is a Safe Strategy'.Eur J Vasc Endovasc Surg. 2015 Jan;49(1):103. doi: 10.1016/j.ejvs.2014.09.014. Eur J Vasc Endovasc Surg. 2015. PMID: 25458437 No abstract available.
-
Re: 'Type II Endoleak: Conservative Management Is a Safe Strategy'.Eur J Vasc Endovasc Surg. 2015 Jan;49(1):103-4. doi: 10.1016/j.ejvs.2014.10.004. Eur J Vasc Endovasc Surg. 2015. PMID: 25458438 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
